Deal announcement

Krzewinski+Partners successfully assisted the Lead Investors of a 45 million euros financing round within EyeD Pharma and UniD Manufacturing.

EyeD Pharma is a leading player in the development of micro-implants ensuring a controlled release of drugs in ophthalmology while UniD Manufacturing will produce these micro-implants in a brand new plant currently under construction.

The Lead Investors consortium is composed of a pool of large private investors, such as Nomainvest, and public ones, such as SRIW and SFPI.

Deal team: Christophe Krzewinski – Samuel Darcheville